Successfully reported this slideshow.

Market Research Report :Otc drug market in india 2014 - Sample

1,912 views

Published on

For the complete report, get in touch with us at: info@netscribes.com

  • Be the first to comment

Market Research Report :Otc drug market in india 2014 - Sample

  1. 1. Insert Cover Image using Slide Master View Do not distort OTC Drug Market - India July 2014
  2. 2. 2 Drivers:  Rising consumer confidence in OTC products  Switch of prescription drugs to OTC widens growth opportunity of OTC  Increasing focus on brand building  Booming retail growth  Changing demographics  Lower price control Challenges: Low penetration in rural areas Preference of home remedies Competitive market Time consuming clinical trial procedures Competition Drivers and Challenges Market Executive Summary  India currently ranks eleventh in the global Over-the-counter (OTC) drug market  OTC drug market in India is valued at INR XX unit in 20--  The market is expected to grow at a CAGR of m% from 20-- to 20-- Public Players Private Players Player 1; Player 2; Player 3; Player 4; Player 5; Player 6; Player 7; Player 8; Player 9; Player 10; Player11 Payer 1; player 2; Player 3; Player 4 OTC DRUG MARKET IN INDIA 2014.PPT
  3. 3. 3 •Macroeconomic Indicators •Introduction •Market Overview •Market Value Chain •Drivers & Challenges •Government Initiatives •Regulations •Competitive Landscape •Recent Developments •Strategic Recommendations •Appendix OTC DRUG MARKET IN INDIA 2014.PPT
  4. 4. 4 Economic Indicators (1/3) 11 12 13 14 15 INR tn Q4 c4 b4 a4 Q3 c3 b3 a3 Q2 d2 c2 b2 a2 Q1 d1 c1 b1 a1 2013-142012-132011-122010-11 GDP at Factor Cost: Quarterly Inflation Rate: Monthly -2 -1 0 1 2 q Aug 2013 - Sep 2013 r Sep 2013 - Oct 2013Jul 2013 - Aug 2013 p Nov 2013 - Dec 2013 t Oct 2013 - Nov 2013 % s OTC DRUG MARKET IN INDIA 2014.PPT
  5. 5. 5 Global OTC drug market is expected to witness a huge growth over the coming years • OTC pharmaceutical is one of the largest segments of the overall pharma market • The market has a size of INR A1 unit in 20-- and is expected to grow at a CAGR of m % from 20-- to 20-- • Cough and cold medicines are the leading contributor in the global market, comprising almost p% of the total market • Major growth is expected to come from the Asia-Pacific region, which is the largest contributor to global sales and accounts for q% of the global market • In 20--,pharmacy retail chains formed the major share of the distribution channel in the global OTC pharma market, accounting for r% of the total value • A large number of drugs are shifting from prescription to OTC, thus drives the market extensively Global Market – Overview Market Size and Growth OTC Drug Distribution – 20-- A% C% B% C B A 0 2 4 6 8 INR XX M% 20--e A6 20--e A5 20--e A4 20--e A3 20-- A2 20-- A1 Note: Revenue fluctuations caused due to the changes in exchange rate OTC DRUG MARKET IN INDIA 2014.PPT
  6. 6. 6 Increasing amount of consumer confidence in OTC products is driving the Indian market • Over-the-counter drug market in India has a huge potential • Indian OTC market had a size of INR X bn in 20-- and is expected to grow at a CAGR of y% from 20-- to 20-- • India currently ranks eleventh in the global OTC market and it is estimated that it will reach ninth position within next five years • Sales channels for OTC drugs are extensive, as they do not require a drug license and can be sold by non chemists as well • Vitamins and minerals segments are the most popular segments, with a share of around Y% Indian Market – Overview Market Size and Growth Source: OTC Drug Distribution – 20-- 0 50 100 150 200 INR YY y% 20--e X6 20--e X5 20--e X4 20--e X3 20-- X2 20-- X1 D4% D3% D2% D1% D4 D3 D2 D1 OTC DRUG MARKET IN INDIA 2014.PPT
  7. 7. 7 Drivers & Challenges – Summary Drivers Rising consumer confidence in OTC products Switch of prescription drugs to OTC widens growth opportunity of OTC Booming retail growth Increasing focus on brand building Changing demographics Low price control Challenges Low penetration in rural areas Preference of home remedies Competitive market Time consuming clinical trial procedures OTC DRUG MARKET IN INDIA 2014.PPT
  8. 8. 8 Government Initiatives – Summary Government Initiatives Reduction in drug prices Other Initiatives Changes in tax structure OTC DRUG MARKET IN INDIA 2014.PPT
  9. 9. 9 SAMPLEPorter’s Five Forces Analysis Competitive Rivalry • Texttext texttext texttext texttext texttext texttext texttext • Texttext texttext texttext texttext texttext texttext texttext Bargaining Power of Buyers • Texttext texttext texttext texttext texttext texttext texttext • Texttext texttext texttext texttext texttext texttext texttext Threat of New Entrants • Texttext texttext texttext texttext texttext texttext texttext • Texttext texttext texttext texttext texttext texttext texttext Impact Low to Medium Impact Medium to High Impact High Bargaining Power of Suppliers • Texttext texttext texttext texttext texttext texttext texttext • Texttext texttext texttext texttext texttext texttext texttext • Texttext texttext texttext texttext texttext texttext texttext Impact Low to Medium Threat of Substitutes • Texttext texttext texttext texttext texttext texttext texttext • Texttext texttext texttext texttext texttext texttext texttext Impact Low OTC DRUG MARKET IN INDIA 2014.PPT
  10. 10. 10 SAMPLECompetitive Benchmarking (1/5) Public Trading Comparables (FY 2013) – Top 3 Companies Company A Company B Company C Market Capitalization (INR mn) Value Value Value Share Price (INR) Value Value Value EV/EBITDA (INR mn) Value Value Value EV/Revenue (INR mn) Value Value Value PE Ratio Value Value Value Note: Top 3 Public companies based on the Market Capitalization, Share Price and PE ratio is as of 18/05/2014 OTC DRUG MARKET IN INDIA 2014.PPT
  11. 11. 11 SAMPLEKey Ratios of Top 3 Companies – Operational Basis (FY 20--) (1/3) Competitive Benchmarking (1/4) -30 -20 -10 0 10 % Player C q3 Player B q2p2 Player A q1p1 Net MarginOperating Margin • X • X OTC DRUG MARKET IN INDIA 2014.PPT
  12. 12. 12 Public: Domestic Company – Company A (1/4) Key People Products and Services Company Information Offices and Centres – India Corporate Address Company A Address Line 1 Address Line 2 Tel No. +91 xx xxxxxxxx Fax No. +91 xx xxxxxxxx Website www.a.com Year of Incorporation 19-- Ticker Symbol xxx Stock Exchange NNN Name Designation Person A Chairman, M.D. Person B GM of Finance Person c President- OTC Division Person D Senior V.P. Sales & Marketing X Head Office Category Products/Services Healthcare Management Nutritional drinks, pharmaceuticals, OTC F&B Drinks and cola OTC DRUG MARKET IN INDIA 2014.PPT
  13. 13. 13 Key Ratios Financial Summary • The company earned a net profit of INR q units in FY 20--, as compared to net profit of INR r units in FY 20-- • The company reported total income of INR p units in FY 20--, registering an increase of t per cent over FY 20-- • The company earned an operating margin of f per cent in FY 20--, a decrease of g percentage points over FY 20-- • The company reported debt to equity ratio of h in FY 20--, an increase of z per cent over FY 20-- Key Financial Performance Indicators Net Profit / Loss Total Income -20 0 20 INR units -40 INR units 2.0 1.5 1.0 0.5 0.0 20-- q p 20-- r o 20-- s n 20-- t m Indicators Value (dd/mm/20--) Market Capitalization (INR) Total Enterprise Value (INR) Particulars y-o-y change (20-- - --) 20-- 20-- 20-- 20-- Profitability Ratios Operating Margin Net Margin Profit Before Tax Margin Return on Equity Return on Capital Employed Return on Working Capital Return on Assets Return on Fixed Assets Cost Ratios Operating costs (% of Sales) Administration costs (% of Sales) Interest costs (% of Sales) Liquidity Ratios Current Ratio Cash Ratio Leverage Ratios Debt to Equity Ratio Debt to Capital Ratio Interest Coverage Ratio Efficiency Ratios Fixed Asset Turnover Asset Turnover Current Asset Turnover Working Capital Turnover Capital Employed Turnover Improved Decline Financial Snapshot Public: Domestic Company – Company A (2/4) OTC DRUG MARKET IN INDIA 2014.PPT
  14. 14. 14 Key Business Segments Key Geographic Segments Business Highlights 20-- z y x 20-- z y x 20-- z y x 20-- z y x zyx 0 20 40 60 80 100 20-- 100% A Company A has been solely operating in India Public: Domestic Company – Company A (3/4) Description News Overview • Company A is an integrated research based company that produces a wide range of generic medicines • Serves customers in over 100 countries with manufacturing facilities in several countries OTC • Has been operating in the OTC industry for the past 12 years Key Initiatives • Is making consistent effort for continual improvement in rural areas with respect to accessibility of medicines OTC DRUG MARKET IN INDIA 2014.PPT
  15. 15. 15 Product Category OTC Products Pain Management Product A, Product B Congestion Management Product C, Product D Healthcare Management Product E, Product F OTC Products Public: Domestic Company – Company A (4/4) OTC DRUG MARKET IN INDIA 2014.PPT
  16. 16. 16 Thank you for the attention About Netscribes, Inc. Netscribes, Inc. is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one-stop shop designed to fulfil clients’ profitability and growth objectives. OTC Drug Market – India report is part of Netscribes’ Healthcare Series. For any queries or customized research requirements, contact us at: Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction. Phone: +91 22 4098 7600 E-Mail: info@netscribes.com OTC DRUG MARKET IN INDIA 2014.PPT

×